ICAM1 and COVID-19: Endothelial damage is closely linked to increased organ failure risks in COVID-19 patients, with studies demonstrating how the virus triggers endothelial cell dysregulation, enhances pro-inflammatory cytokine production, oxidative stress, and expression of adhesion molecules such as ICAM1, VCAM1, and E-selectin (16–19).